| Cathryn A Goldberg, MD | |
|
801 S Washington Street, Edward Hospital, Naperville, IL 60566-7060 | |
| (630) 355-0450 | |
| (630) 527-3911 |
| Full Name | Cathryn A Goldberg |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 36 Years |
| Location | 801 S Washington Street, Naperville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558449587 | NPI | - | NPPES |
| 0360946803 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZH0000X | Pathology - Hematology | (Illinois) | Primary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists And Laboratory Physicians Llc | 0446582175 | 12 |
| Dupage Medical Group Ltd | 5496667941 | 1209 |
| Laboratory And Pathology Diagnostics Llc | 4486630886 | 13 |
News Archive
MicroStrategy® Incorporated, a leading worldwide provider of enterprise software platforms, today announced that NHS Scotland's Golden Jubilee National Hospital has deployed the MicroStrategy Analytics Platform™ and MicroStrategy Mobile™ to monitor, report, and analyze over 200 quality indicators consisting of patient care, staffing, and performance metrics.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.
Technical Resources International, Inc. is pleased to announce that TRI has been awarded the Regulatory Support Center contract by the U.S. National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health, Department of Health and Human Services.
› Verified 7 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
MicroStrategy® Incorporated, a leading worldwide provider of enterprise software platforms, today announced that NHS Scotland's Golden Jubilee National Hospital has deployed the MicroStrategy Analytics Platform™ and MicroStrategy Mobile™ to monitor, report, and analyze over 200 quality indicators consisting of patient care, staffing, and performance metrics.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.
Technical Resources International, Inc. is pleased to announce that TRI has been awarded the Regulatory Support Center contract by the U.S. National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health, Department of Health and Human Services.
› Verified 7 days ago
| Entity Name | Laboratory & Pathology Diagnostics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285713826 PECOS PAC ID: 4486630886 Enrollment ID: O20040626000144 |
News Archive
MicroStrategy® Incorporated, a leading worldwide provider of enterprise software platforms, today announced that NHS Scotland's Golden Jubilee National Hospital has deployed the MicroStrategy Analytics Platform™ and MicroStrategy Mobile™ to monitor, report, and analyze over 200 quality indicators consisting of patient care, staffing, and performance metrics.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.
Technical Resources International, Inc. is pleased to announce that TRI has been awarded the Regulatory Support Center contract by the U.S. National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health, Department of Health and Human Services.
› Verified 7 days ago
| Entity Name | Associated Pathologists And Laboratory Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568903565 PECOS PAC ID: 0446582175 Enrollment ID: O20191030002562 |
News Archive
MicroStrategy® Incorporated, a leading worldwide provider of enterprise software platforms, today announced that NHS Scotland's Golden Jubilee National Hospital has deployed the MicroStrategy Analytics Platform™ and MicroStrategy Mobile™ to monitor, report, and analyze over 200 quality indicators consisting of patient care, staffing, and performance metrics.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.
Technical Resources International, Inc. is pleased to announce that TRI has been awarded the Regulatory Support Center contract by the U.S. National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health, Department of Health and Human Services.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cathryn A Goldberg, MD Department 4387, Carol Stream, IL 60122-4387 Ph: (630) 355-0450 | Cathryn A Goldberg, MD 801 S Washington Street, Edward Hospital, Naperville, IL 60566-7060 Ph: (630) 355-0450 |
News Archive
MicroStrategy® Incorporated, a leading worldwide provider of enterprise software platforms, today announced that NHS Scotland's Golden Jubilee National Hospital has deployed the MicroStrategy Analytics Platform™ and MicroStrategy Mobile™ to monitor, report, and analyze over 200 quality indicators consisting of patient care, staffing, and performance metrics.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.
Technical Resources International, Inc. is pleased to announce that TRI has been awarded the Regulatory Support Center contract by the U.S. National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health, Department of Health and Human Services.
› Verified 7 days ago
Dr. Karl Michael Napekoski, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S. Washington Street, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Sarah B Clark, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Richard R Anderson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Theodore E Troe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Rohit Gupta, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Dwight W Morrow, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 |